🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

To an LLM, a novel discovery is indistinguishable from an error.

It’s been a tough few weeks. My 10yo daughter was diagnosed with a very rare, aggressive cancer called interdigitating dendritic cell sarcoma (IDCS). I’m reaching out to identify clinicians/patients who have encountered pediatric IDCS, indeterminate dendritic cell histiocytosis

Counterpoint -- Lilly and Novo added about $1T in market cap in the last 5 years on the back of a single consumer biotech product. Human health and longevity is the largest market in the entire world, hands down. Would you pay more than you pay Apple every year to live longer,

bio is collectively the most asymmetrically skewed to the upside vertical in investing over the next decade.

Announcing achira.ai  Achira will usher in the next phase of AI for drug discovery building atomistic foundation models for biomolecular simulation to harness the explosive growth of available computation and the frontiers of physics-based synthetic data

the stereotypical tech CEO thinks biotech people have never heard about computers, and it's just another industry waiting for disruption. the biotech CEO is busy listing 50 reasons why it's naïve and won't work. Both extremes are wrong in different ways - it is indeed much more

Great take. Requires a massive degree of optimism to envision and build a future that is different. Especially tackling fundamental challenges such as disease. Great work is happening.

Great pod on virtual cell. Exactly the NOETIK multimodal data layers. Let’s go!

Powering precision cancer treatment with #AI. 💻🔬 go.aws/4lL0KHh Learn how NOETIK, together with #AWS & NVIDIA AI, is applying advanced machine learning techniques to develop novel immunotherapies that will save lives.

If you missed NOETIK posters at #AACR2025, they're now live on our website. OCTO-Virtual Cell model, now featuring patient level embeddings for discovery and translation + first data from Perturb-map functional genetics platform!

“You need a ‘world model’ of biology in order to run accurate simulations.” We agree: noetik.ai/octo

Unveiling Lux Science Helpline We're seeing compelling science from academia more than ever, yet crucial ideas are facing slowdowns when American science matters more than ever. Lux is dedicating $100M to continue propelling these ideas forward. Reach out to us.

Cellular context matters. In this NOETIK virtual cell experiment, we simulate a virtual T cell traversing a tumor and show how gene expression changes for a subset of genes (right) as the T cell traverses different tumor microenvironments.

Today we announce an exciting collab with Agenus ($AGEN) to deploy NOETIK virtual cell foundation models to support predictive biomarkers development for BOT/BAL. AI / Foundation models have redefined preclinical. Today, we begin a new era where AI will impact clinical

Great coverage of our collaboration with Agenus to use Virtual Cell Models of patient biology to impact clinical success. Together, we are directing the most advanced AI in biology to tackle real therapeutics challenges for patients. genengnews.com/topics/artific…

Great event! Thanks for hosting, really enjoyed chatting with John Axerio.

Massive NOETIK data, individual cells captured from human and mouse tissues over time across modalities. These are from actual tissues not cell cultures.

Joining Noetik owlposting.com/p/joining-noet… after a restful month of funemployment, i joined NOETIK last week. this essay explains my current beliefs about the ML-bio field, why I joined Noetik, and what they are working on 2.8k words, 14 minutes reading time